Relationship between Patient Characteristics and the Timing of Provision of Explanation about DNAR to Patients with Advanced Lung Cancer.
Adult
Aged
Aged, 80 and over
Carcinoma, Non-Small-Cell Lung
/ psychology
Clinical Decision-Making
Communication
Female
Humans
Lung Neoplasms
/ psychology
Male
Middle Aged
Neoplasm Recurrence, Local
/ psychology
Physician-Patient Relations
Physicians
/ psychology
Prognosis
Resuscitation Orders
/ psychology
Retrospective Studies
Time Factors
Do Not Attempt Resuscitation
advance care planning
lung cancer
palliative care
Journal
Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241
Informations de publication
Date de publication:
01 Dec 2020
01 Dec 2020
Historique:
pubmed:
8
8
2020
medline:
7
4
2021
entrez:
8
8
2020
Statut:
ppublish
Résumé
Objective The aim of the present study was to analyze the relationship between the patient characteristics and the timing of provision of an explanation about "Do Not Attempt Resuscitation (DNAR)" by attending physicians to advanced lung cancer patients. Methods We conducted a retrospective analysis of patients with advanced or postoperative recurrent lung cancer in whom systemic therapy was initiated between 2015 and 2016. Results The data of a total of 74 patients with lung cancer, including 59 patients with non-small cell lung cancer and 15 with small cell lung cancer were analyzed. The median overall survival of the patients was 10.0 months. Records of the explanation about DNAR by the physicians were available for 57 of the 74 (77.0%) patients. For 48 (64.9%) patients, the explanation was provided after the discontinuation of anticancer treatment, and for 9 (12.2%) patients, it was provided during the course of anticancer treatment. The provision of an explanation about DNAR during the course of treatment was associated with a poor performance status at the start of treatment (p=0.028), the tumor histology (p=0.037), the presence of driver gene mutation in the tumor (p=0.029), and shorter survival after the discontinuation of anticancer treatment (p<0.001). Conclusion The results suggested that the timing of provision of an explanation about DNAR was associated with patient characteristics and the predicted prognosis.
Identifiants
pubmed: 32759584
doi: 10.2169/internalmedicine.4704-20
pmc: PMC7759716
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2989-2994Références
Jpn J Clin Oncol. 2015 Mar;45(3):261-6
pubmed: 25480983
JAMA Intern Med. 2014 Apr;174(4):620-4
pubmed: 24493203
Del Med J. 2012 Apr;84(4):117-21
pubmed: 22856102
Tidsskr Nor Laegeforen. 2013 Feb 19;133(4):417-21
pubmed: 23423208
Med Oncol. 2014 Sep;31(9):154
pubmed: 25108600
J Pain Symptom Manage. 2017 May;53(5):821-832.e1
pubmed: 28062339
J Clin Oncol. 2012 Feb 1;30(4):394-400
pubmed: 22203758
Cancer. 2001 Oct 1;92(7):1905-12
pubmed: 11745264
N Engl J Med. 2010 Aug 19;363(8):733-42
pubmed: 20818875
Support Care Cancer. 1999 May;7(3):128-33
pubmed: 10335930
N Engl J Med. 2010 Apr 1;362(13):1211-8
pubmed: 20357283